highly significantp < 0.001
For our primary outcomes measures, we found a highly significant difference in PCL-S scores between W1 and W7 for both the propranolol group [ t (28) = 5.683 p < 0.001] and the placebo group [ t (28) = 7.410 p < 0.001] (Fig. 2A ).